Breaking Boundaries: PharmAla Teams Up with Yale for Groundbreaking Clinical Trial Using LaNeo MDMA
PharmAla Biotech Holdings Inc. Enters into Contract to Supply MDMA for Clinical Trial at Yale University TORONTO, Nov. 07, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF) A Step Forward in Research and Development PharmAla Biotech Holdings Inc., a leading biotechnology company specializing in the research, development,…